Veradermics is trading at $103.13, up +4.69%, with no clearly reported September 8, 2026 catalyst explaining the move.
- Veradermics is scheduled for investor meetings at the Wells Fargo 21st Annual Healthcare Conference on September 8, 2026.
- Available coverage does not explicitly link the conference to the gain.
- Broader markets are lower, so market sentiment does not explain the advance.